Literature DB >> 26141522

Genetic Counseling, Reproductive Behavior and Future Reproductive Intentions of People with Neurofibromatosis Type 1 (NF1).

M Ponder1, F Murton, N Hallowell, H Statham, J Green, M Richards.   

Abstract

Neurofibromatosis type 1(NF1) is a complex and variable inherited disorder. The complexity and variability present particular difficulty for genetic counseling. Thirty-three people with NF1 of reproductive age were interviewed about their experience of genetic counseling, their past reproductive behavior and future intentions. One third reported having had no genetic counseling or not having it until after their first child. In part, this may be due to delay in diagnosis but also indicates poor access to genetic services. Only three people had ever been offered prenatal genetic testing and only one had accepted. Although testing is still technically difficult, the greatest deterrent to uptake of prenatal testing for NF1 is the variability of the disorder. However, six of the 17 people planning future pregnancies would want a test with a view to termination if necessary. Others would welcome testing in order to be prepared but not to terminate. We discuss some of the factors which influence reproductive decision making for people with NF1 and some of the difficulties in genetic counseling in such a variable and complex disorder.

Entities:  

Year:  1998        PMID: 26141522     DOI: 10.1023/A:1022020000598

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  11 in total

1.  Segregation analysis of peripheral neurofibromatosis (NF1).

Authors:  M Littler; N E Morton
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

2.  Diagnostic delay in neurofibromatosis type 1.

Authors:  M H Cnossen; F J Smit; A de Goede-Bolder; P G Frets; H J Duivenvoorden; M F Niermeijer
Journal:  Eur J Pediatr       Date:  1997-06       Impact factor: 3.183

Review 3.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

Authors:  D H Gutmann; A Aylsworth; J C Carey; B Korf; J Marks; R E Pyeritz; A Rubenstein; D Viskochil
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

4.  Systemically-Based Psychotherapeutic Techniques in Genetic Counseling.

Authors:  D L Eunpu
Journal:  J Genet Couns       Date:  1997-03       Impact factor: 2.537

Review 5.  Impact of genetic counseling: a review of published follow-up studies.

Authors:  G Evers-Kiebooms; H van den Berghe
Journal:  Clin Genet       Date:  1979-06       Impact factor: 4.438

6.  Gender response to neurofibromatosis 1.

Authors:  J Ablon
Journal:  Soc Sci Med       Date:  1996-01       Impact factor: 4.634

Review 7.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling.

Authors:  S M Huson; D A Compston; P S Harper
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

8.  Genetic counseling -- the postcounseling period: II. Making reproductive choices.

Authors:  A Lippman-Hand; F C Fraser
Journal:  Am J Med Genet       Date:  1979

9.  Prenatal diagnosis and presymptomatic detection of neurofibromatosis type 1.

Authors:  M Upadhyaya; A Fryer; J MacMillan; W Broadhead; S M Huson; P S Harper
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

10.  Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families.

Authors:  C M Benjamin; A Colley; D Donnai; H Kingston; R Harris; L Kerzin-Storrar
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

View more
  2 in total

1.  A Qualitative Study to Explore the Views and Attitudes towards Prenatal Testing in Adults Who Have Muenke Syndrome and their Partners.

Authors:  Julie Phipps; Heather Skirton
Journal:  J Genet Couns       Date:  2017-03-22       Impact factor: 2.537

2.  The fertility willingness and acceptability of preimplantation genetic testing in Chinese patients with autosomal dominant polycystic kidney disease.

Authors:  Mingji Sun; Cheng Xue; Yunhui Lu; Yiyi Ma; Ting Pan; Xiaoliu Wang; Li Fan; Jiandong Shen; Yan Hao; Danxia Zheng; Junhua Li; Mingxu Li; Yaping He; Changlin Mei
Journal:  BMC Nephrol       Date:  2020-04-25       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.